Focusing on rarer cancers in Europe

May 8, 2017

For more information on this new initiative, please click here EURACAN.

 

Recent News

New Research Trial – The NELMAS trial

New Research Trial – The NELMAS trial

NELMAS - An international multi-centre, stratified, open, randomized, comparator-controlled, parallel-group phase II study comparing adjuvant treatment with 177Lu-DOTATATE (Lutathera®) to best supportive care in patients after resection of neuroendocrine liver...

read more
CABINET Phase III trial update 

CABINET Phase III trial update 

Final results, published by Ipsen, Monday 16th September.  The number of people newly diagnosed with NETs is believed to be rising due to increasing awareness and better methods of diagnosis, with approximately 35 in every 100,000 people currently living with NETs...

read more